LEAMINGTON, Ontario, Nov. 18, 2022 — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced that its medical cannabis division, Tilray Medical, has launched Take Back Control, a new platform developed to connect women with free resources on medical cannabis and to help destigmatize the use of medical cannabis in women’s healthcare practices. The Take Back Control platform connects people with free consultations with healthcare practitioners focused on women’s health providing expert advice on medical cannabis.
Take Back Control is designed to help women make informed decisions about medical cannabis and assists them along their path to discovering how medical cannabis can play a part in their daily healthcare practices. Available now in Canada, Take Back Control simplifies the steps to meet with a healthcare practitioner to help women through their needs and challenges, providing professional guidance to help kick-start their medical cannabis health care journey.
Tilray Medical is the recognized global leader in medical cannabis and is committed to helping people take back control of their healthcare choices and treatment. Unlike some other alternatives, medical cannabis lets people become an active participant in their healthcare journey.
For more information on Take Back Control visit www.takebackcontrolnow.ca
About Tilray Medical
Tilray Medical is dedicated to transforming lives and fostering dignity for patients in need through safe and reliable access to a global portfolio of medical cannabis brands, including Tilray, Aphria, Broken Coast, and Symbios. Tilray grew from being one of the first companies to become an approved licensed producer of medical cannabis in Canada to building the first EU-GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany. Today, Tilray Medical is one of the biggest suppliers of medical cannabis brands to patients, physicians, hospitals, pharmacies, researchers, and governments, in 20 countries and across five continents.
For more information on Tilray Medical, visit Tilray Medical Canada, Tilray Medical Australia, Tilray Medical Australia-New Zealand, Tilray Medical Europe
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very best life and providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.
For more information on how we open a world of well-being, visit www.Tilray.com and follow @Tilray on Instagram and Twitter.